• Saudi Arabia-based healthtech Madeed has raised $400,000 in a pre-seed round led by Vision Ventures, with participation from Saudi angel investors Mashhoor Aldubayan, Mazen Aldarrab, and Abdulla Nadeem Elyas.
• Founded in 2025 by Adam Bataineh, the startup is building a preventive health platform focused on early disease risk detection through advanced biomarkers and laboratory testing.
• The funding will support product development, the expansion of clinical and laboratory partnerships, and the launch of its first member cohort in Saudi Arabia as the company moves into early commercialisation.

Press release:

Madeed, a Saudi preventive health and longevity startup, has raised $400,000 in a pre-seed funding round led by Vision Ventures, with participation from Saudi angel investors Mashhoor Aldubayan, Mazen Aldarrab, and Abdulla Nadeem Elyas.

Founded by Dr. Adam Bataineh, Madeed is building an end-to-end preventive health platform focused on shifting healthcare away from reactive treatment toward early detection. The company uses advanced laboratory testing to identify disease risk factors, often before symptoms appear, by screening biomarkers associated with hundreds of potential conditions.

At the core of Madeed’s offering is a membership-based model combining diagnostics, physician-led interpretation, and personalised intervention. Members receive advanced blood and biomarker testing, detailed health reports, and clinical reviews covering key areas such as metabolic health, hormonal balance, cardiovascular risk, and inflammation.

The platform complements diagnostics with personalised health protocols spanning lifestyle optimisation, nutrition, and supplements. A key differentiator is Madeed’s customised daily supplement packs, individually designed based on lab results, positioning the product as a data-driven alternative to generic wellness supplements.

The fresh capital will be used to accelerate product development, expand clinical and laboratory partnerships across the region, and launch Madeed’s first cohort of members, with an initial focus on the Saudi market. The startup is now entering its early commercialisation phase, strengthening its provider network and testing product-market fit ahead of broader regional expansion.